The Possible Immunological Pathways for the Variable Immunopathogenesis of COVID—19 Infections among Healthy Adults, Elderly and Children
More details
Hide details
Professor in Virology and Infectious diseases, M.B., Ch.B., Ph.D. at Microbiology Department, College of Medicine, Alnahrain University, Baghdad, IRAQ
Associate Professor in Biotechnology and Infectious diseases, Ph.D. at Microbiology Department, College of Medicine, University of Baghdad, Baghdad, IRAQ
Online publication date: 2020-03-21
Publication date: 2020-03-21
Electron J Gen Med 2020;17(4):em202
Novel Coronavirus, COVID-19 discovered in December, 2019 in Wuhan, China started a world-wide epidemic. It is not clear till now what is the pathogenesis of this virus infection in human or the exact strategies of host immune response in combating this novel threat to human beings. However, morbidity and mortality of COVID-19 infections vary widely from asymptomatic, mild to deadly critical. Strangely, children were found to be protected from severe or deadly critical infections, while elderly and immunocompromised adults are most affected badly by this virus. It is necessary to disclose the possible viral and host interactions that lead to such variable morbid effects among patients of COVID-19 infections.
Schoeman D, Fielding BC. Coronavirus envelope protein: current knowledge. Virol J, 2019;16(1):69. PMid:31133031 PMCid:PMC6537279.
Hui DS, E IA, Madani TA, Ntoumi F, Kock R, Dar O, Ippolito G, McHugh TD, Memish ZA, Drosten C, Zumla A, Petersen E. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis, 2020;91:264-6. PMid:31953166.
Coronaviridae Study Group of the International Committee on Taxonomy of, V. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol, 2020. PMid:32123347.
Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet, 2020;395(10224):565-574.
Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 2020. PMid:32015507.
Liu K, Fang YY, Deng Y, Liu W, Wang MF, Ma JP, et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin Med J (Engl), 2020. PMCid:PMC7028197.
Krammer F, Smith GJD, Fouchier RAM, Peiris M, Kedzierska K, Doherty PC, et al. Influenza. Nat Rev Dis Primers, 2018;4(1):3. PMid:29955068.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 2020;395(10223):497-506.
Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med, 2020. PMid:31995857.
Liu Y, Gayle AA, Wilder-Smith A, Rocklov J. The reproductive number of COVID-19 is higher compared to SARS coronavirus. J Travel Med, 2020. PMid:32052846.
Jamison DT. In: Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans DB, et al. (Eds.). Investing in Health. In Disease Control Priorities in Developing Countries. Washington DC, 2006.
Molteni M. Kids Can Get Covid-19. They Just Don’t Get That Sick. Available at: (Accessed 10 March 2020).
Tian S, Hu W, Niu L, Liu H, Xu H, Xiao S-Y. Pulmonary pathology of early phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer. Journal of Thoracic Oncology, 2020.
Mckeever, A. From blood storms to honeycomb lungs, here’s an organ-by-organ look at how COVID-19 harms humans. Available at: https://www.nationalgeographic... (Accessed 10 March 2020).
McCloskey B, Heymann DL. SARS to novel coronavirus - old lessons and new lessons. Epidemiol Infect, 2020;148:e22. PMid:32019614 PMCid:PMC7026896.
Beck-Schimmer B, Schimmer RC, Pasch T. The airway compartment: chambers of secrets. News Physiol Sci, 2004;19:129-32. PMid:15143208.
Al Kahlout RA, Nasrallah GK, Farag EA, Wang L, Lattwein E, Muller MA, et al. Comparative Serological Study for the Prevalence of Anti-MERS Coronavirus Antibodies in High- and Low-Risk Groups in Qatar. J Immunol Res, 2019;2019:1386740. PMid:30906787 PMCid:PMC6398027.
Chan KH, Chan JF, Tse H, Chen H, Lau CC, Cai JP, et al. Cross-reactive antibodies in convalescent SARS patients’ sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests. J Infect, 2013;67(2):130-40. PMid:23583636.
Begley S. Experts envision two scenarios if the new coronavirus isn’t contained. Available at: (Accessed 15 March 2020).